A US-based biotech company has been granted permission to start a clinical trial and find out whether it is possible to reverse brain death.
Brain death virtually means the end of a life and no one is going to bring it back at any cost. But a new report could be ray a hope for those who have underwent this miserable situation.
Don't Miss: Incredible Pokemon Gifts
A US-based biotech company has been given permission to conduct experiments on such patients and to find out whether it is possible to reverse brain death.
According to The Telegraph, the research will focus on 20 patients who have been clinically declared dead as a result of traumatic brain injury and there are no chances of their regaining consciousness. They are only alive through life support.
In the trail, multiple techniques including injecting stem cells and cocktail of peptides, laser and nerve stimulation therapies will be used to see if their brains could be alive again. The patients will be monitored for several months to witness any sign of progress or regeneration in the upper spinal cord – the region of brain directly linked to breathing and heartbeat.
“This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime,” said Dr Ira Pastor, the CEO of Bioquark Inc. “To undertake such a complex initiative, we are combining biologic regenerative medicine tools with other exiting medical devices typically used for stimulation of the central nervous system, in patients with other severe disorders of consciousness.”
“We hope to see results within the first two to three months.”
A person is declared dead when his brain stem cells are severely damaged and impossible to repair. Brain death is considered irreversible as of right now but researchers believe if these techniques work, brain stem cells could restart life again. The process is similar to animals like salamanders that have the natural ability regrow their entire limbs and regenerate parts of major organs with the help of their immune system.
Dr Sergei Paylian, Founder, President, and Chief Science Officer of the company says. “Through our study, we will gain unique insights into the state of human brain death, which will have important connections to future therapeutic development for other severe disorders of consciousness, such as coma and the vegetative and minimally conscious states as well as a range of degenerative CNS conditions including Alzheimer’s and Parkinson’s disease.”
Don't Miss: iPhone 8: Everything You Need to Know